These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15451157)

  • 1. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.
    Boos CJ
    Eur Heart J; 2004 Oct; 25(19):1761-2. PubMed ID: 15451157
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.
    Dernellis J; Panaretou M
    Eur Heart J; 2004 Jul; 25(13):1100-7. PubMed ID: 15231367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.
    Conway DS; Lip GY
    Eur Heart J; 2004 Oct; 25(19):1761. PubMed ID: 15451156
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucocorticoids, Kounis syndrome and the prevention of atrial fibrillation.
    Mallioris CN; Kounis NG
    Eur Heart J; 2004 Dec; 25(23):2175-6. PubMed ID: 15571845
    [No Abstract]   [Full Text] [Related]  

  • 5. Is atrial fibrillation an inflammatory disease?
    Liu T; Li G
    Med Hypotheses; 2005; 64(6):1237-8. PubMed ID: 15823725
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
    Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
    Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New hope for the prevention of recurrent atrial fibrillation.
    Abdelhadi RH; Chung MK; Van Wagoner DR
    Eur Heart J; 2004 Jul; 25(13):1089-90. PubMed ID: 15231364
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation.
    Dernellis J; Panaretou M
    Am Heart J; 2005 Nov; 150(5):1064. PubMed ID: 16290998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C-reactive protein and atrial fibrillation. An old marker looking for a new target].
    Hernández Madrid A
    Rev Esp Cardiol; 2006 Feb; 59(2):94-8. PubMed ID: 16540029
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can measurement of CRP and BNP concentrations be helpful in predicting relapses and therapy of atrial fibrillation?].
    Mikółka R
    Wiad Lek; 2007; 60(9-10):439-44. PubMed ID: 18350718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and lone atrial fibrillation: potential confounders.
    Boos CJ; Lip GY
    Am J Cardiol; 2006 Oct; 98(7):991-2. PubMed ID: 16996892
    [No Abstract]   [Full Text] [Related]  

  • 13. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation.
    Rotter M; Jaïs P; Vergnes MC; Nurden P; Takahashi Y; Sanders P; Rostock T; Hocini M; Sacher F; Haïssaguerre M
    J Am Coll Cardiol; 2006 Mar; 47(6):1231-3. PubMed ID: 16545659
    [No Abstract]   [Full Text] [Related]  

  • 14. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in the genesis and perpetuation of atrial fibrillation.
    Engelmann MD; Svendsen JH
    Eur Heart J; 2005 Oct; 26(20):2083-92. PubMed ID: 15975993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.
    Lellouche N; Sacher F; Wright M; Nault I; Brottier J; Knecht S; Matsuo S; Lomas O; Hocini M; Haïssaguerre M; Jaïs P
    Europace; 2009 May; 11(5):662-4. PubMed ID: 19351632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid induced atrial fibrillation.
    Iqbal FM; Beeharilal PS; Sadat K; Mohajer R; Lewis BE
    Compr Ther; 2008; 34(2):111-4. PubMed ID: 18833788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation.
    Tziakas DN; Chalikias GK; Stakos DA; Papanas N; Chatzikyriakou SV; Mitrousi K; Maltezos E; Boudoulas H
    Am J Cardiol; 2008 Jan; 101(2):199-202. PubMed ID: 18178406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.